These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 387813)

  • 21. Multiplex Bead Assay for the Serological Surveillance of Measles and Rubella.
    Coughlin MM; Smits G; Matson Z; van Binnendijk R; Bankamp B
    Methods Mol Biol; 2024; 2808():225-246. PubMed ID: 38743374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme immunoassays for viral diseases.
    Bidwell DE; Bartlett A; Voller A
    J Infect Dis; 1977 Oct; 136 Suppl():S274-8. PubMed ID: 198490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of monoclonal antibodies to human immunoglobulin M in "capture" assays for measles and rubella immunoglobulin M.
    Forghani B; Myoraku CK; Schmidt NJ
    J Clin Microbiol; 1983 Sep; 18(3):652-7. PubMed ID: 6355153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raised antibody titres to measles and rubella viruses in chronic active hepatitis.
    Triger DR; MacCallum FO; Kurtz JB; Wright R
    Lancet; 1972 Mar; 1(7752):665-7. PubMed ID: 4125166
    [No Abstract]   [Full Text] [Related]  

  • 25. [Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine].
    Terada K; Ouchi K; Ihara T; Okada K; Numazaki K
    Kansenshogaku Zasshi; 2008 Sep; 82(5):414-8. PubMed ID: 18975583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles immunity in HIV-infected children.
    Walter EB; Katz SL; Bellini WJ
    Pediatr AIDS HIV Infect; 1994 Oct; 5(5):300-4. PubMed ID: 11361371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay.
    Dhiman N; Jespersen DJ; Rollins LO; Harring JA; Beito EM; Binnicker MJ
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):346-9. PubMed ID: 20638602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Incidence and prevalence of antibodies to measles, herpesvirus infections, mumps and rubella in the cerebrospinal fluid and serum of subjects with abiotrophic-degenerative type diseases of the central nervous system].
    Nicoletti F; Castro A; Tempera G; Falsaperla A; Pero G
    Boll Soc Ital Biol Sper; 1978 Jan; 54(1):12-5. PubMed ID: 216379
    [No Abstract]   [Full Text] [Related]  

  • 29. Subcellular fractions in rubella immunoassays.
    Tuokko H; Toivonen V; Salmi A
    Eur J Clin Microbiol; 1984 Feb; 3(1):19-24. PubMed ID: 6368224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
    Yoshida N; Tsumura N; Toyomasu K; Sagawa K
    Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dot immunobinding assay for simultaneous detection of specific immunoglobulin G antibodies to measles virus, mumps virus, and rubella virus.
    Condorelli F; Ziegler T
    J Clin Microbiol; 1993 Mar; 31(3):717-9. PubMed ID: 8458970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serodiagnosis of rubella virus infection].
    Matsuno T; Ohtahara M
    Nihon Rinsho; 1990 Feb; 48 Suppl():340-3. PubMed ID: 2355552
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of a highly specific and sensitive rubella immunoglobulin M antibody capture enzyme immunoassay that uses enzyme-labeled antigen.
    Seppänen H
    J Clin Microbiol; 1990 Apr; 28(4):719-23. PubMed ID: 2185260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody levels to multiple viral antigens in systemic lupus erythematosus and some other connective tissue diseases.
    Vesikari T; Laitinen O
    Ann Clin Res; 1974 Aug; 6(4):207-14. PubMed ID: 4372935
    [No Abstract]   [Full Text] [Related]  

  • 35. [EIA-IgG antibody measles prevention level estimated from measles neutralizing, particle agglutination and hemagglutination-inhibition antibody titer].
    Takayama N; Saika S; Ichinohe S
    Kansenshogaku Zasshi; 2009 Sep; 83(5):519-24. PubMed ID: 19860253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.
    Bolotin S; Lim G; Dang V; Crowcroft N; Gubbay J; Mazzulli T; Schabas R
    PLoS One; 2017; 12(8):e0181172. PubMed ID: 28850604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serological assay of measles and rubella immunity in a sample of infantile population in palermo (author's transl)].
    Arista S; Ammatuna P; Leggio M; Chiarini A
    Ann Sclavo; 1980; 22(1):42-8. PubMed ID: 7247483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new latex test and a new enzyme immunoassay for determination of rubella immunity.
    Simor AE; Chua R; Low DE
    J Clin Microbiol; 1988 Aug; 26(8):1582-3. PubMed ID: 3049661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the specificity of a commercial human parvovirus B19 IgM assay.
    Jensen IP; Vestergaard BF
    Clin Diagn Virol; 1997 Feb; 7(3):133-7. PubMed ID: 9126681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
    Wolff MH; Marklein G; Schneweis KE; Stifter G
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.